Breast cancer incidence after the start of mammography screening in Denmark

被引:37
作者
Olsen, AH
Jensen, A
Njor, SH
Villadsen, E
Schwartz, W
Vejborg, I
Lynge, E
机构
[1] Univ Copenhagen, Inst Publ Hlth, DK-2200 Copenhagen N, Denmark
[2] Univ Copenhagen Hosp, Ctr Diagnost Imaging, DK-2100 Copenhagen O, Denmark
[3] Odense Univ Hosp, Mammog Screening Clin, DK-5000 Odense, Denmark
关键词
malignant neoplasms; breast; mammography;
D O I
10.1038/sj.bjc.6600712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mammography screening may lead to overdiagnosis of asymptomatic breast cancers, that would otherwise not have given rise to clinical symptoms. This aspect was studied in three regional screening programmes in Denmark, which started in Copenhagen municipality, Fyn county, and Frederiksberg municipality in 199 1, 1993, and 1994, respectively. In these regions, we compared time trends in incidence of invasive breast cancer with the rest of Denmark. Since the number of clinical mammograms was relatively low, it was reasonable to assume that the breast cancer incidence outside the three screening regions represented the incidence of a population with low-intensity opportunistic screening. In Copenhagen and Fyn, a prevalence peak in incidence was seen during the first invitation round. During the subsequent invitation rounds, the incidence dropped to a level in dine with the incidence expected without screening. The pattern was different in the small municipality of Frederiksberg, where the sensitivity was low during the first invitation round. Inclusion of screen-detected ductal carcinoma in situ cases did not change these results. The experiences from Copenhagen and Fyn show that organised mammography screening can operate without overdiagnosis of breast cancer. (C) 2003 Cancer Research UK.
引用
收藏
页码:362 / 365
页数:4
相关论文
共 9 条
[1]  
Andreasen A H, 1994, Ugeskr Laeger, V156, P6517
[2]  
Chen HH, 1997, J EPIDEMIOL BIOSTAT, V2, P9
[3]  
Lynge E, 1998, APMIS Suppl, V83, P1
[4]   BREAST-CANCER SCREENING WITH MAMMOGRAPHY - OVERVIEW OF SWEDISH RANDOMIZED TRIALS [J].
NYSTROM, L ;
RUTQVIST, LE ;
WALL, S ;
LINDGREN, A ;
LINDQVIST, M ;
RYDEN, S ;
ANDERSSON, I ;
BJURSTAM, N ;
FAGERBERG, G ;
FRISELL, J ;
TABAR, L ;
LARSSON, LG .
LANCET, 1993, 341 (8851) :973-978
[5]  
Pociot F, 1986, Ugeskr Laeger, V148, P471
[6]  
*SUNDHEDSSTYRELSEN, 1989, MAMMOGRAFISCREENING
[7]  
*SUNDHEDSSTYRELSEN, 2001, CANC INC DENM
[8]  
*SUNDHEDSSTYRELSEN, 1997, TIDL OPSP BEH BRYSTK
[9]  
WANG H, 2002, EPIDEMIOLOGICAL STUD, P10